Expiratory Volume i et sekund (FEV1)) imellem behandlingsgrupperne med en lille fordel til patienter behandlet med sammenligningsprodukt.
In clinical trials small but consistent treatment group differences in decline of pulmonary function (particularly Forced Expiratory Volume in one second (FEV1)) favouring comparator treated subjects have been observed.